Tilak Mandadi compensation by year
CVS HEALTH Summary Compensation Table · all 4 fiscal years held| Component | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $437,500 | $1,000,000 | $1,000,000 | $1,000,000 |
| Bonus | $2,773,375 | $0 | $0 | $0 |
| Stock awards | $9,799,983 | $4,874,990 | $8,199,843 | $5,599,965 |
| Option awards | $0 | $1,624,993 | $1,299,989 | $1,399,996 |
| Non-equity incentive | $981,000 | $1,246,000 | $583,000 | $2,561,000 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $0 | $135,862 | $278,511 | $416,755 |
| Total | $13,991,858 | $8,881,845 | $11,361,343 | $10,977,716 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CVS HEALTH Corp DEF 14A filed April 3, 2026, accession 0001308179-26-000201, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CVS HEALTH Corp filed document, accession 0001308179-26-000201. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 52,757 | $4,186,796 | — |
| PSU | 50,893 | $4,038,868 | — |
| RSU | 33,417 | $2,651,973 | — |
| RSU | 30,732 | $2,438,892 | — |
| RSU | 20,594 | $1,634,340 | — |
| RSU | 12,255 | $972,557 | — |
| Option | 87,336 | — | $67.98 |
| Option | 50,940 | — | $79.56 |
| Option | 48,248 | — | $74.31 |
Per the Outstanding Equity Awards at Fiscal Year-End table in CVS HEALTH Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed April 3, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-08 | Sale | — | 69,551 | $89.58 | 10,133 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments CVS HEALTH discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $1,500,000 | $20,819,458 | $14,996 | $26,084,454 |
| Involuntary for cause | $0 | $-20,819,458 | $0 | $-20,819,458 |
| Voluntary resignation | $0 | $0 | $0 | $0 |
| Death | $0 | $20,819,458 | $0 | $20,819,458 |
| Involuntary termination without cause | $1,500,000 | $12,391,515 | $14,996 | $13,906,511 |
| Retirement | $0 | $0 | $0 | $0 |
Per the Potential Payments Upon Termination or Change in Control table in CVS HEALTH Corp's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
CVS HEALTH’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| J. David Joyner | President and Chief Executive Officer | $21,214,084 |
| Prem Shah | Executive Vice President and Group President | $13,379,210 |
| Steven Nelson | Executive Vice President and President, Aetna | $11,587,110 |
| Tilak Mandadi · this page | Executive Vice President, Ventures and Chief Experience and Technology Officer | $10,977,716 |
| Brian Newman | Executive Vice President and Chief Financial Officer | $9,420,508 |
| Thomas Cowhey | Former Executive Vice President and Chief Financial Officer | $6,715,138 |
Tilak Mandadi's compensation dossier, CVS HEALTH
You have read Tilak Mandadi's totals and holdings. The dossier adds each equity grant CVS HEALTH disclosed for Tilak Mandadi and CVS HEALTH's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full CVS HEALTH compensation record
free company briefThis page is one person within CVS HEALTH's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CVS HEALTH proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CVS HEALTH's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CVS HEALTH's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CVS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.